{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T03:38:49Z","timestamp":1786765129854,"version":"build-2736575974"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T00:00:00Z","timestamp":1645315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T00:00:00Z","timestamp":1645315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00774-021-01305-3","type":"journal-article","created":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T05:02:18Z","timestamp":1645333338000},"page":"508-517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mortality factors in recurrent parathyroid cancer: a pooled analysis"],"prefix":"10.1007","volume":"40","author":[{"given":"Wen-Hsuan","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chieh","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,20]]},"reference":[{"key":"1305_CR1","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1359\/jbmr.081018","volume":"23","author":"C Marcocci","year":"2008","unstructured":"Marcocci C, Cetani F, Rubin MR, Silverberg SJ, Pinchera A, Bilezikian JP (2008) Parathyroid carcinoma (in eng). J Bone Miner Res 23:1869\u20131880. https:\/\/doi.org\/10.1359\/jbmr.081018","journal-title":"J Bone Miner Res"},{"key":"1305_CR2","unstructured":"Board PDQATE (2002) Parathyroid Cancer Treatment (PDQ\u00ae): Health Professional Version. PDQ Cancer Information Summaries. National Cancer Institute (US), Bethesda (MD)"},{"key":"1305_CR3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.clon.2010.04.007","volume":"22","author":"B Givi","year":"2010","unstructured":"Givi B, Shah JP (2010) Parathyroid carcinoma (in eng). Clin Oncol (R Coll Radiol) 22:498\u2013507. https:\/\/doi.org\/10.1016\/j.clon.2010.04.007","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1305_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/01.cco.0000198019.53606.2b","volume":"18","author":"SE Rodgers","year":"2006","unstructured":"Rodgers SE, Perrier ND (2006) Parathyroid carcinoma (in eng). Curr Opin Oncol 18:16\u201322. https:\/\/doi.org\/10.1097\/01.cco.0000198019.53606.2b","journal-title":"Curr Opin Oncol"},{"key":"1305_CR5","doi-asserted-by":"publisher","first-page":"R441","DOI":"10.1530\/erc-19-0135","volume":"26","author":"F Cetani","year":"2019","unstructured":"Cetani F, Marcocci C, Torregrossa L, Pardi E (2019) Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors (in eng). Endocr Relat Cancer 26:R441\u2013R464. https:\/\/doi.org\/10.1530\/erc-19-0135","journal-title":"Endocr Relat Cancer"},{"key":"1305_CR6","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.beem.2018.11.002","volume":"32","author":"AS Salcuni","year":"2018","unstructured":"Salcuni AS, Cetani F, Guarnieri V, Nicastro V, Romagnoli E, de Martino D, Scillitani A, Cole DEC (2018) Parathyroid carcinoma (in eng). Best Pract Res Clin Endocrinol Metab 32:877\u2013889. https:\/\/doi.org\/10.1016\/j.beem.2018.11.002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1305_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1530\/eje-06-0720","volume":"156","author":"F Cetani","year":"2007","unstructured":"Cetani F, Ambrogini E, Viacava P, Pardi E, Fanelli G, Naccarato AG, Borsari S, Lemmi M, Berti P, Miccoli P, Pinchera A, Marcocci C (2007) Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? (in eng). Eur J Endocrinol 156:547\u2013554. https:\/\/doi.org\/10.1530\/eje-06-0720","journal-title":"Eur J Endocrinol"},{"key":"1305_CR8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S1055-3207(18)30242-4","volume":"7","author":"E Kebebew","year":"1998","unstructured":"Kebebew E, Clark OH (1998) Parathyroid adenoma, hyperplasia, and carcinoma: localization, technical details of primary neck exploration, and treatment of hypercalcemic crisis (in eng). Surg Oncol Clin N Am 7:721\u2013748","journal-title":"Surg Oncol Clin N Am"},{"key":"1305_CR9","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/1097-0142(197303)31:3<600::aid-cncr2820310316>3.0.co;2-0","volume":"31","author":"A Schantz","year":"1973","unstructured":"Schantz A, Castleman B (1973) Parathyroid carcinoma. A study of 70 cases (in eng). Cancer 31:600\u2013605. https:\/\/doi.org\/10.1002\/1097-0142(197303)31:3%3c600::aid-cncr2820310316%3e3.0.co;2-0","journal-title":"Cancer"},{"key":"1305_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s11864-001-0028-2","volume":"2","author":"E Kebebew","year":"2001","unstructured":"Kebebew E (2001) Parathyroid carcinoma (in eng). Curr Treat Options Oncol 2:347\u2013354. https:\/\/doi.org\/10.1007\/s11864-001-0028-2","journal-title":"Curr Treat Options Oncol"},{"key":"1305_CR11","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/(sici)1097-0142(19990801)86:3<538::aid-cncr25>3.0.co;2-k","volume":"86","author":"SA Hundahl","year":"1999","unstructured":"Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1999) Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985\u20131995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society (in eng). Cancer 86:538\u2013544. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19990801)86:3%3c538::aid-cncr25%3e3.0.co;2-k","journal-title":"Cancer"},{"key":"1305_CR12","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1245\/s10434-010-1003-6","volume":"17","author":"N Talat","year":"2010","unstructured":"Talat N, Schulte KM (2010) Clinical presentation, staging and long-term evolution of parathyroid cancer (in eng). Ann Surg Oncol 17:2156\u20132174. https:\/\/doi.org\/10.1245\/s10434-010-1003-6","journal-title":"Ann Surg Oncol"},{"key":"1305_CR13","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1210\/jc.2011-1571","volume":"96","author":"A Harari","year":"2011","unstructured":"Harari A, Waring A, Fernandez-Ranvier G, Hwang J, Suh I, Mitmaker E, Shen W, Gosnell J, Duh QY, Clark O (2011) Parathyroid carcinoma: a 43-year outcome and survival analysis (in eng). J Clin Endocrinol Metab 96:3679\u20133686. https:\/\/doi.org\/10.1210\/jc.2011-1571","journal-title":"J Clin Endocrinol Metab"},{"key":"1305_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13402-012-0100-x","volume":"35","author":"V Guarnieri","year":"2012","unstructured":"Guarnieri V, Battista C, Muscarella LA, Bisceglia M, de Martino D et al (2012) CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort (in eng). Cell Oncol (Dordr) 35:411\u2013422. https:\/\/doi.org\/10.1007\/s13402-012-0100-x","journal-title":"Cell Oncol (Dordr)"},{"key":"1305_CR15","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s40618-016-0447-3","volume":"39","author":"F Cetani","year":"2016","unstructured":"Cetani F, Pardi E, Marcocci C (2016) Update on parathyroid carcinoma (in eng). J Endocrinol Invest 39:595\u2013606. https:\/\/doi.org\/10.1007\/s40618-016-0447-3","journal-title":"J Endocrinol Invest"},{"key":"1305_CR16","doi-asserted-by":"publisher","DOI":"10.2217\/ije-2017-0011","author":"KL Long","year":"2018","unstructured":"Long KL, Sippel RS (2018) Current and future treatments for parathyroid carcinoma. Int J Endocrine Oncol. https:\/\/doi.org\/10.2217\/ije-2017-0011","journal-title":"Int J Endocrine Oncol"},{"key":"1305_CR17","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/bf02067369","volume":"16","author":"K Sandelin","year":"1992","unstructured":"Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO (1992) Prognostic factors in parathyroid cancer: a review of 95 cases (in eng). World J Surg 16:724\u2013731. https:\/\/doi.org\/10.1007\/bf02067369","journal-title":"World J Surg"},{"key":"1305_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00003072-199901000-00005","volume":"24","author":"S Al-Sobhi","year":"1999","unstructured":"Al-Sobhi S, Ashari LH, Ingemansson S (1999) Detection of metastatic parathyroid carcinoma with Tc-99m sestamibi imaging (in eng). Clin Nucl Med 24:21\u201323. https:\/\/doi.org\/10.1097\/00003072-199901000-00005","journal-title":"Clin Nucl Med"},{"key":"1305_CR19","first-page":"1132","volume":"96","author":"DB Calandra","year":"1984","unstructured":"Calandra DB, Chejfec G, Foy BK, Lawrence AM, Paloyan E (1984) Parathyroid carcinoma: biochemical and pathologic response to DTIC (in eng). Surgery 96:1132\u20131137","journal-title":"Surgery"},{"key":"1305_CR20","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.surg.2014.08.005","volume":"156","author":"KT Hsu","year":"2014","unstructured":"Hsu KT, Sippel RS, Chen H, Schneider DF (2014) Is central lymph node dissection necessary for parathyroid carcinoma? (in eng). Surgery 156:1336\u20131341. https:\/\/doi.org\/10.1016\/j.surg.2014.08.005","journal-title":"Surgery"},{"key":"1305_CR21","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1245\/s10434-016-5256-6","volume":"23","author":"S Young","year":"2016","unstructured":"Young S, Wu JX, Li N, Yeh MW, Livhits MJ (2016) More extensive surgery may not improve survival over parathyroidectomy alone in parathyroid carcinoma (in eng). Ann Surg Oncol 23:2898\u20132904. https:\/\/doi.org\/10.1245\/s10434-016-5256-6","journal-title":"Ann Surg Oncol"},{"key":"1305_CR22","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1245\/aso.2005.03.036","volume":"12","author":"KP Kleinpeter","year":"2005","unstructured":"Kleinpeter KP, Lovato JF, Clark PB, Wooldridge T, Norman ES, Bergman S, Perrier ND (2005) Is parathyroid carcinoma indeed a lethal disease? (in eng). Ann Surg Oncol 12:260\u2013266. https:\/\/doi.org\/10.1245\/aso.2005.03.036","journal-title":"Ann Surg Oncol"},{"key":"1305_CR23","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1245\/s10434-015-4672-3","volume":"22","author":"EA Asare","year":"2015","unstructured":"Asare EA, Sturgeon C, Winchester DJ, Liu L, Palis B, Perrier ND, Evans DB, Winchester DP, Wang TS (2015) Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the national cancer data base (NCDB) (in eng). Ann Surg Oncol 22:3990\u20133995. https:\/\/doi.org\/10.1245\/s10434-015-4672-3","journal-title":"Ann Surg Oncol"},{"key":"1305_CR24","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/jcem.86.2.7207","volume":"86","author":"E Shane","year":"2001","unstructured":"Shane E (2001) Clinical review 122: Parathyroid carcinoma (in eng). J Clin Endocrinol Metab 86:485\u2013493. https:\/\/doi.org\/10.1210\/jcem.86.2.7207","journal-title":"J Clin Endocrinol Metab"},{"key":"1305_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1530\/ec-13-0046","volume":"2","author":"F Cetani","year":"2013","unstructured":"Cetani F, Banti C, Pardi E, Borsari S, Viacava P, Miccoli P, Torregrossa L, Basolo F, Pelizzo MR, Rugge M, Pennelli G, Gasparri G, Papotti M, Volante M, Vignali E, Saponaro F, Marcocci C (2013) CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer (in eng). Endocr Connect 2:186\u2013195. https:\/\/doi.org\/10.1530\/ec-13-0046","journal-title":"Endocr Connect"},{"key":"1305_CR26","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.surg.2007.09.014","volume":"142","author":"M Iihara","year":"2007","unstructured":"Iihara M, Okamoto T, Suzuki R, Kawamata A, Nishikawa T, Kobayashi M, Obara T (2007) Functional parathyroid carcinoma: Long-term treatment outcome and risk factor analysis (in eng). Surgery 142:936\u2013943. https:\/\/doi.org\/10.1016\/j.surg.2007.09.014","journal-title":"Surgery"},{"key":"1305_CR27","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1245\/s10434-019-07451-3","volume":"26","author":"EA Asare","year":"2019","unstructured":"Asare EA, Silva-Figueroa A, Hess KR, Busaidy N, Graham PH, Grubbs EG, Lee JE, Williams MD, Perrier ND (2019) Risk of distant metastasis in parathyroid carcinoma and its effect on survival: a retrospective review from a high-volume center (in eng). Ann Surg Oncol 26:3593\u20133599. https:\/\/doi.org\/10.1245\/s10434-019-07451-3","journal-title":"Ann Surg Oncol"},{"key":"1305_CR28","first-page":"1040","volume":"114","author":"T Obara","year":"1993","unstructured":"Obara T, Okamoto T, Ito Y, Yamashita T, Kawano M, Nishi T, Tani M, Sato K, Demura H, Fujimoto Y (1993) Surgical and medical management of patients with pulmonary metastasis from parathyroid carcinoma (in eng). Surgery 114:1040\u20131048","journal-title":"Surgery"},{"key":"1305_CR29","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.amjsurg.2010.09.025","volume":"202","author":"M Schaapveld","year":"2011","unstructured":"Schaapveld M, Jorna FH, Aben KK, Haak HR, Plukker JT, Links TP (2011) Incidence and prognosis of parathyroid gland carcinoma: a population-based study in The Netherlands estimating the preoperative diagnosis (in eng). Am J Surg 202:590\u2013597. https:\/\/doi.org\/10.1016\/j.amjsurg.2010.09.025","journal-title":"Am J Surg"},{"key":"1305_CR30","doi-asserted-by":"publisher","first-page":"634","DOI":"10.4158\/ep-2018-0538","volume":"25","author":"Y Hu","year":"2019","unstructured":"Hu Y, Bi Y, Cui M, Zhang X, Su Z, Wang M, Hua S, Liao Q, Zhao Y (2019) The influence of surgical extent and parafibromin staining on the outcome of parathyroid carcinoma: 20-year experience from a single institute (in eng). Endocr Pract 25:634\u2013641. https:\/\/doi.org\/10.4158\/ep-2018-0538","journal-title":"Endocr Pract"},{"key":"1305_CR31","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/modpathol.2010.236","volume":"24","author":"JE Witteveen","year":"2011","unstructured":"Witteveen JE, Hamdy NA, Dekkers OM, Kievit J, van Wezel T, Teh BT, Romijn JA, Morreau H (2011) Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma (in eng). Modern Pathol 24:688\u2013697. https:\/\/doi.org\/10.1038\/modpathol.2010.236","journal-title":"Modern Pathol"},{"key":"1305_CR32","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1007\/s00268-014-2455-9","volume":"38","author":"L Zhao","year":"2014","unstructured":"Zhao L, Sun LH, Liu DM, He XY, Tao B, Ning G, Liu JM, Zhao HY (2014) Copy number variation in CCND1 gene is implicated in the pathogenesis of sporadic parathyroid carcinoma (in eng). World J Surg 38:1730\u20131737. https:\/\/doi.org\/10.1007\/s00268-014-2455-9","journal-title":"World J Surg"},{"key":"1305_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10549-018-4968-7","volume":"173","author":"E Chang","year":"2019","unstructured":"Chang E, Mougalian SS, Adelson KB, Young MR, Yu JB (2019) Association between prolonged metastatic free interval and recurrent metastatic breast cancer survival: findings from the SEER database (in eng). Breast Cancer Res Treat 173:209\u2013216. https:\/\/doi.org\/10.1007\/s10549-018-4968-7","journal-title":"Breast Cancer Res Treat"},{"key":"1305_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00402-020-03417-3","author":"MH Younis","year":"2020","unstructured":"Younis MH, Fuentes-Rivera L, Summers S, Pretell-Mazzini J (2020) Survival in patients with carcinomas presenting with bone metastasis at diagnosis: a SEER population-based cohort study (in eng). Arch Orthop Trauma Surg. https:\/\/doi.org\/10.1007\/s00402-020-03417-3","journal-title":"Arch Orthop Trauma Surg"},{"key":"1305_CR35","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1148\/radiographics.21.5.g01se251283","volume":"21","author":"MD Murphey","year":"2001","unstructured":"Murphey MD, Nomikos GC, Flemming DJ, Gannon FH, Temple HT, Kransdorf MJ (2001) From the archives of AFIP. Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation (in eng). Radiographics 21:1283\u20131309. https:\/\/doi.org\/10.1148\/radiographics.21.5.g01se251283","journal-title":"Radiographics"},{"key":"1305_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4103\/0971-3026.137049","volume":"24","author":"F Del Grande","year":"2014","unstructured":"Del Grande F, Farahani SJ, Carrino JA, Chhabra A (2014) Bone marrow lesions: A systematic diagnostic approach (in eng). Indian J Radiol Imaging 24:279\u2013287. https:\/\/doi.org\/10.4103\/0971-3026.137049","journal-title":"Indian J Radiol Imaging"},{"key":"1305_CR37","doi-asserted-by":"publisher","first-page":"972","DOI":"10.2214\/ajr.125.4.972","volume":"125","author":"JD Osmond 3rd","year":"1975","unstructured":"Osmond JD 3rd, Pendergrass HP, Potsaid MS (1975) Accuracy of 99mTC-diphosphonate bone scans and roentgenograms in the detection of prostate, breast and lung carcinoma metastases (in eng). Am J Roentgenol Radium Ther Nucl Med 125:972\u2013977. https:\/\/doi.org\/10.2214\/ajr.125.4.972","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"1305_CR38","doi-asserted-by":"publisher","unstructured":"Isaac A, Dalili D, Dalili D, Weber MA (2020) State-of-the-art imaging for diagnosis of metastatic bone disease (in eng). Radiologe (Modernste Bildgebung zur Diagnose von Knochenmetastasen.) https:\/\/doi.org\/10.1007\/s00117-020-00666-6","DOI":"10.1007\/s00117-020-00666-6"},{"key":"1305_CR39","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s00259-007-0712-y","volume":"35","author":"B Kemps","year":"2008","unstructured":"Kemps B, van Ufford HQ, Creyghton W, de Haas M, Baarslag HJ, Rinkes IB, de Klerk J (2008) Brown tumors simulating metastases on FDG PET in a patient with parathyroid carcinoma (in eng). Eur J Nucl Med Mol Imaging 35:850. https:\/\/doi.org\/10.1007\/s00259-007-0712-y","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1305_CR40","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s11914-019-00545-7","volume":"17","author":"BS Mulholland","year":"2019","unstructured":"Mulholland BS, Forwood MR, Morrison NA (2019) Monocyte Chemoattractant protein-1 (MCP-1\/CCL2) drives activation of bone remodelling and skeletal metastasis (in eng). Curr Osteoporos Rep 17:538\u2013547. https:\/\/doi.org\/10.1007\/s11914-019-00545-7","journal-title":"Curr Osteoporos Rep"},{"key":"1305_CR41","unstructured":"Tewari BN, Singh Baghel K, Tripathi C, Dubey P, Bhatt ML, Kumar V, Mati Goel M, Singh Negi MP, Misra S (2016) A study on local expression of NF-\u03baB, CCL2 and their involvement in intratumoral macrophage infiltration in breast cancer (in eng). Cell Mol Biol (Noisy-le-grand) 62:116\u201325"},{"key":"1305_CR42","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1210\/jc.2013-3031","volume":"99","author":"P Vellanki","year":"2014","unstructured":"Vellanki P, Lange K, Elaraj D, Kopp PA, El Muayed M (2014) Denosumab for management of parathyroid carcinoma-mediated hypercalcemia (in eng). J Clin Endocrinol Metab 99:387\u2013390. https:\/\/doi.org\/10.1210\/jc.2013-3031","journal-title":"J Clin Endocrinol Metab"},{"key":"1305_CR43","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1210\/jc.2007-0585","volume":"92","author":"SJ Silverberg","year":"2007","unstructured":"Silverberg SJ, Rubin MR, Faiman C, Peacock M, Shoback DM, Smallridge RC, Schwanauer LE, Olson KA, Klassen P, Bilezikian JP (2007) Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma (in eng). J Clin Endocrinol Metab 92:3803\u20133808. https:\/\/doi.org\/10.1210\/jc.2007-0585","journal-title":"J Clin Endocrinol Metab"},{"key":"1305_CR44","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/s0140-6736(98)06469-1","volume":"353","author":"AR Bradwell","year":"1999","unstructured":"Bradwell AR, Harvey TC (1999) Control of hypercalcaemia of parathyroid carcinoma by immunisation (in eng). Lancet (London, England) 353:370\u2013373. https:\/\/doi.org\/10.1016\/s0140-6736(98)06469-1","journal-title":"Lancet (London, England)"},{"key":"1305_CR45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1507\/endocrj.k09e-283","volume":"57","author":"I Horie","year":"2010","unstructured":"Horie I, Ando T, Inokuchi N, Mihara Y, Miura S, Imaizumi M, Usa T, Kinoshita N, Sekine I, Kamihara S, Eguchi K (2010) First Japanese patient treated with parathyroid hormone peptide immunization for refractory hypercalcemia caused by metastatic parathyroid carcinoma (in eng). Endocr J 57:287\u2013292. https:\/\/doi.org\/10.1507\/endocrj.k09e-283","journal-title":"Endocr J"},{"key":"1305_CR46","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1210\/jc.2018-01151","volume":"104","author":"P Piranavan","year":"2019","unstructured":"Piranavan P, Li Y, Brown E, Kemp EH, Trivedi N (2019) Immune Checkpoint inhibitor-induced hypoparathyroidism associated with calcium-sensing receptor-activating autoantibodies (in eng). J Clin Endocrinol Metab 104:550\u2013556. https:\/\/doi.org\/10.1210\/jc.2018-01151","journal-title":"J Clin Endocrinol Metab"},{"key":"1305_CR47","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s12020-019-02136-z","volume":"67","author":"M Sarquis","year":"2020","unstructured":"Sarquis M, Marx SJ, Beckers A, Bradwell AR, Simonds WF, Bicalho MAC, Daly AF, Betea D, Friedman E, De Marco L (2020) Long-term remission of disseminated parathyroid cancer following immunotherapy (in eng). Endocrine 67:204\u2013208. https:\/\/doi.org\/10.1007\/s12020-019-02136-z","journal-title":"Endocrine"},{"key":"1305_CR48","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/350569a0","volume":"350","author":"EH Blackburn","year":"1991","unstructured":"Blackburn EH (1991) Structure and function of telomeres (in eng). Nature 350:569\u2013573. https:\/\/doi.org\/10.1038\/350569a0","journal-title":"Nature"},{"key":"1305_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20122887","author":"B Donati","year":"2019","unstructured":"Donati B, Ciarrocchi A (2019) Telomerase and telomeres biology in thyroid cancer (in eng). Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20122887","journal-title":"Int J Mol Sci"},{"key":"1305_CR50","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1006\/bbrc.1999.1320","volume":"265","author":"A Falchetti","year":"1999","unstructured":"Falchetti A, Becherini L, Martineti V, Morelli A, Benvenuti S, Picariello L, Gennari L, Lampugnani R, Bordi C, Brandi ML (1999) Telomerase repeat amplification protocol (TRAP): A new molecular marker for parathyroid carcinoma (in eng). Biochem Biophys Res Commun 265:252\u2013255. https:\/\/doi.org\/10.1006\/bbrc.1999.1320","journal-title":"Biochem Biophys Res Commun"},{"key":"1305_CR51","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1359\/jbmr.041123","volume":"20","author":"A Falchetti","year":"2005","unstructured":"Falchetti A, Franchi A, Bordi C, Mavilia C, Masi L, Cioppi F, Recenti R, Picariello L, Marini F, Del Monte F, Ghinoi V, Martineti V, Tanini A, Brandi ML (2005) Azidothymidine induces apoptosis and inhibits cell growth and telomerase activity of human parathyroid cancer cells in culture (in eng). J Bone Mineral Res 20:410\u2013418. https:\/\/doi.org\/10.1359\/jbmr.041123","journal-title":"J Bone Mineral Res"},{"key":"1305_CR52","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00268-002-6409-2","volume":"26","author":"M Kammori","year":"2002","unstructured":"Kammori M, Nakamura K, Kanauchi H, Obara T, Kawahara M, Mimura Y, Kaminishi M, Takubo K (2002) Consistent decrease in telomere length in parathyroid tumors but alteration in telomerase activity limited to malignancies: preliminary report (in eng). World J Surg 26:1083\u20131087. https:\/\/doi.org\/10.1007\/s00268-002-6409-2","journal-title":"World J Surg"},{"key":"1305_CR53","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1046\/j.1365-2265.2003.01642.x","volume":"58","author":"M Kammori","year":"2003","unstructured":"Kammori M, Nakamura K, Ogawa T, Mafune K, Tatutomi Y, Obara T, Onoda N, Fujiwara M, Izumiyama-Shimomura N, Mori M, Kaminishi M, Takubo K (2003) Demonstration of human telomerase reverse transcriptase (hTERT) in human parathyroid tumours by in situ hybridization with a new oligonucleotide probe (in eng). Clin Endocrinol 58:43\u201348. https:\/\/doi.org\/10.1046\/j.1365-2265.2003.01642.x","journal-title":"Clin Endocrinol"},{"key":"1305_CR54","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1530\/eje.0.1450161","volume":"145","author":"AK Velin","year":"2001","unstructured":"Velin AK, Herder A, Johansson KJ, Trulsson LM, Smeds S (2001) Telomerase is not activated in human hyperplastic and adenomatous parathyroid tissue (in eng). Eur J Endocrinol 145:161\u2013164. https:\/\/doi.org\/10.1530\/eje.0.1450161","journal-title":"Eur J Endocrinol"},{"key":"1305_CR55","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1530\/ec-19-0260","volume":"8","author":"S Storvall","year":"2019","unstructured":"Storvall S, Leijon H, Ryh\u00e4nen E, Louhimo J, Haglund C, Schalin-J\u00e4ntti C, Arola J (2019) Somatostatin receptor expression in parathyroid neoplasms (in eng). Endocr Connect 8:1213\u20131223. https:\/\/doi.org\/10.1530\/ec-19-0260","journal-title":"Endocr Connect"},{"key":"1305_CR56","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1002\/humu.23337","volume":"38","author":"L Cardoso","year":"2017","unstructured":"Cardoso L, Stevenson M, Thakker RV (2017) Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma (in eng). Hum Mutat 38:1621\u20131648. https:\/\/doi.org\/10.1002\/humu.23337","journal-title":"Hum Mutat"},{"key":"1305_CR57","doi-asserted-by":"publisher","first-page":"E360","DOI":"10.1210\/jc.2014-3238","volume":"100","author":"W Yu","year":"2015","unstructured":"Yu W, McPherson JR, Stevenson M, van Eijk R, Heng HL, Newey P, Gan A, Ruano D, Huang D, Poon SL, Ong CK, van Wezel T, Cavaco B, Rozen SG, Tan P, Teh BT, Thakker RV, Morreau H (2015) Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion (in eng). J Clin Endocrinol Metab 100:E360\u2013E364. https:\/\/doi.org\/10.1210\/jc.2014-3238","journal-title":"J Clin Endocrinol Metab"},{"key":"1305_CR58","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/ijc.31948","volume":"144","author":"M Cui","year":"2019","unstructured":"Cui M, Hu Y, Bi Y, Wang W, Wang M, Zhang X, Zhang R, Wang P, Su Z, Gao X, Wang J, Li Q, Liao Q, Zhao Y (2019) Preliminary exploration of potential molecular therapeutic targets in recurrent and metastatic parathyroid carcinomas (in eng). Int J Cancer 144:525\u2013532. https:\/\/doi.org\/10.1002\/ijc.31948","journal-title":"Int J Cancer"},{"key":"1305_CR59","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/1097-0142(197204)29:4<1016::aid-cncr2820290449>3.0.co;2-m","volume":"29","author":"CS Hill Jr","year":"1972","unstructured":"Hill CS Jr, Ouais SG, Leiser AE (1972) Long-term administration of calcitonin for hypercalcemia secondary to recurrent parathyroid carcinoma (in eng). Cancer 29:1016\u20131020. https:\/\/doi.org\/10.1002\/1097-0142(197204)29:4%3c1016::aid-cncr2820290449%3e3.0.co;2-m","journal-title":"Cancer"},{"key":"1305_CR60","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/00000658-198104000-00006","volume":"193","author":"MW Flye","year":"1981","unstructured":"Flye MW, Brennan MF (1981) Surgical resection of metastatic parathyroid carcinoma (in eng). Ann Surg 193:425\u2013435. https:\/\/doi.org\/10.1097\/00000658-198104000-00006","journal-title":"Ann Surg"},{"key":"1305_CR61","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/1097-0142(19820115)49:2<388::aid-cncr2820490230>3.0.co;2-f","volume":"49","author":"KA Aldinger","year":"1982","unstructured":"Aldinger KA, Hickey RC, Ibanez ML, Samaan NA (1982) Parathyroid carcinoma: a clinical study of seven cases of functioning and two cases of nonfunctioning parathyroid cancer (in eng). Cancer 49:388\u2013397. https:\/\/doi.org\/10.1002\/1097-0142(19820115)49:2%3c388::aid-cncr2820490230%3e3.0.co;2-f","journal-title":"Cancer"},{"key":"1305_CR62","first-page":"906","volume":"94","author":"BJ Anderson","year":"1983","unstructured":"Anderson BJ, Samaan NA, Vassilopoulou-Sellin R, Ordonez NG, Hickey RC (1983) Parathyroid carcinoma: features and difficulties in diagnosis and management (in eng). Surgery 94:906\u2013915","journal-title":"Surgery"},{"key":"1305_CR63","first-page":"978","volume":"110","author":"K Sandelin","year":"1991","unstructured":"Sandelin K, Thompson NW, Bondeson L (1991) Metastatic parathyroid carcinoma: dilemmas in management (in eng). Surgery 110:978\u2013986","journal-title":"Surgery"},{"key":"1305_CR64","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0266-4356(93)90174-u","volume":"31","author":"EA Masson","year":"1993","unstructured":"Masson EA, MacFarlane IA, Bodmer CW, Vaughan ED (1993) Parathyroid carcinoma presenting with a brown tumour of the mandible in a young man (in eng). Br J Oral Maxillofac Surg 31:117\u2013119. https:\/\/doi.org\/10.1016\/0266-4356(93)90174-u","journal-title":"Br J Oral Maxillofac Surg"},{"key":"1305_CR65","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3949\/ccjm.60.4.331","volume":"60","author":"AG Hakaim","year":"1993","unstructured":"Hakaim AG, Esselstyn CB Jr (1993) Parathyroid carcinoma: 50-year experience at The Cleveland clinic foundation (in eng). Cleve Clin J Med 60:331\u2013335. https:\/\/doi.org\/10.3949\/ccjm.60.4.331","journal-title":"Cleve Clin J Med"},{"key":"1305_CR66","first-page":"882","volume":"114","author":"JT Vetto","year":"1993","unstructured":"Vetto JT, Brennan MF, Woodruf J, Burt M (1993) Parathyroid carcinoma: diagnosis and clinical history (in eng). Surgery 114:882\u2013892","journal-title":"Surgery"},{"key":"1305_CR67","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2169\/internalmedicine.33.697","volume":"33","author":"H Koyano","year":"1994","unstructured":"Koyano H, Shishiba Y, Shimizu T, Suzuki N, Nakazawa H, Tachibana S, Murata H, Furui S (1994) Successful treatment by surgical removal of bone metastasis producing PTH: new approach to the management of metastatic parathyroid carcinoma (in eng). Intern Med 33:697\u2013702. https:\/\/doi.org\/10.2169\/internalmedicine.33.697","journal-title":"Intern Med"},{"key":"1305_CR68","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/pgmj.70.821.231","volume":"70","author":"PG Newrick","year":"1994","unstructured":"Newrick PG, Braatvedt GD, Webb AJ, Sheffield E, Corrall RJ (1994) Prolonged remission of hypercalcaemia due to parathyroid carcinoma with pamidronate (in eng). Postgrad Med J 70:231\u2013232. https:\/\/doi.org\/10.1136\/pgmj.70.821.231","journal-title":"Postgrad Med J"},{"key":"1305_CR69","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/oxfordjournals.jjco.a023192","volume":"26","author":"ER van Haaren","year":"1996","unstructured":"van Haaren ER, Kievit J, Huysmans HA, van de Velde CJ (1996) Successful resection of hepatic and pulmonary metastases in a patient with parathyroid carcinoma (in eng). Jpn J Clin Oncol 26:99\u2013102. https:\/\/doi.org\/10.1093\/oxfordjournals.jjco.a023192","journal-title":"Jpn J Clin Oncol"},{"key":"1305_CR70","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/ndt\/14.2.449","volume":"14","author":"CC Tseng","year":"1999","unstructured":"Tseng CC, Huang JJ, Wang MC, Lan RR, Sung JM, Chen FF (1999) Parathyroid carcinoma with multiple lung metastases (in eng). Nephrol Dial Transplant 14:449\u2013451. https:\/\/doi.org\/10.1093\/ndt\/14.2.449","journal-title":"Nephrol Dial Transplant"},{"key":"1305_CR71","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s002560050022","volume":"29","author":"TG Abrahams","year":"2000","unstructured":"Abrahams TG, Hanks P, Jones M (2000) Hyperfunctioning parathyroid carcinoma (in eng). Skeletal Radiol 29:112\u2013115. https:\/\/doi.org\/10.1007\/s002560050022","journal-title":"Skeletal Radiol"},{"key":"1305_CR72","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1530\/eje.0.1430749","volume":"143","author":"T Rasmuson","year":"2000","unstructured":"Rasmuson T, Kristoffersson A, Boquist L (2000) Positive effect of radiotherapy and surgery on hormonally active pulmonary metastases of primary parathyroid carcinoma (in eng). Eur J Endocrinol 143:749\u2013754. https:\/\/doi.org\/10.1530\/eje.0.1430749","journal-title":"Eur J Endocrinol"},{"key":"1305_CR73","first-page":"448","volume":"7","author":"G Bednarek-Tupikowska","year":"2001","unstructured":"Bednarek-Tupikowska G, To\u0142\u0142oczko T, Tupikowski W, Bogda\u0144ska M, Karwacki J, Medra\u015b M, Milewicz A (2001) Coexistence of parathyroid carcinoma and non-medullary carcinoma of the thyroid (in eng). Med Sci Monit 7:448\u2013456","journal-title":"Med Sci Monit"},{"key":"1305_CR74","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1053\/ejso.2001.1122","volume":"27","author":"C Dotzenrath","year":"2001","unstructured":"Dotzenrath C, Goretzki PE, Sarbia M, Cupisti K, Feldkamp J, R\u00f6her HD (2001) Parathyroid carcinoma: problems in diagnosis and the need for radical surgery even in recurrent disease (in eng). Eur J Surg Oncol 27:383\u2013389. https:\/\/doi.org\/10.1053\/ejso.2001.1122","journal-title":"Eur J Surg Oncol"},{"key":"1305_CR75","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/hed.10297","volume":"25","author":"JB Rufener","year":"2003","unstructured":"Rufener JB, Cohen JI (2003) Metachronous spread of parathyroid carcinoma to a retropharyngeal lymph node (in eng). Head Neck 25:968\u2013971. https:\/\/doi.org\/10.1002\/hed.10297","journal-title":"Head Neck"},{"key":"1305_CR76","first-page":"266","volume":"102","author":"HY Ou","year":"2003","unstructured":"Ou HY, Hung CJ, Hsu WH, Yu EH, Wu TJ (2003) Variability of clinical presentations in three cases of parathyroid carcinoma (in eng). J Formos Med Assoc 102:266\u2013269","journal-title":"J Formos Med Assoc"},{"key":"1305_CR77","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejso.2004.06.014","volume":"31","author":"J Kirkby-Bott","year":"2005","unstructured":"Kirkby-Bott J, Lewis P, Harmer CL, Smellie WJ (2005) One stage treatment of parathyroid cancer (in eng). Eur J Surg Oncol 31:78\u201383. https:\/\/doi.org\/10.1016\/j.ejso.2004.06.014","journal-title":"Eur J Surg Oncol"},{"key":"1305_CR78","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1097\/00006123-200104000-00052","volume":"48","author":"D Tyler 3rd","year":"2001","unstructured":"Tyler D 3rd, Mandybur G, Dhillon G, Fratkin J (2001) Intracranial metastatic parathyroid carcinoma: case report (in eng). Neurosurgery 48:937\u2013939. https:\/\/doi.org\/10.1097\/00006123-200104000-00052","journal-title":"Neurosurgery"},{"key":"1305_CR79","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/01.rlu.0000259623.79805.2d","volume":"32","author":"K Placzkowski","year":"2007","unstructured":"Placzkowski K, Christian R, Chen H (2007) Radioguided parathyroidectomy for recurrent parathyroid cancer (in eng). Clin Nucl Med 32:358\u2013360. https:\/\/doi.org\/10.1097\/01.rlu.0000259623.79805.2d","journal-title":"Clin Nucl Med"},{"key":"1305_CR80","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12672-010-0042-6","volume":"1","author":"JE Witteveen","year":"2010","unstructured":"Witteveen JE, Haak HR, Kievit J, Morreau H, Romijn JA, Hamdy NA (2010) Challenges and pitfalls in the management of parathyroid carcinoma: 17-year follow-up of a case and review of the literature (in eng). Horm Cancer 1:205\u2013214. https:\/\/doi.org\/10.1007\/s12672-010-0042-6","journal-title":"Horm Cancer"},{"key":"1305_CR81","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.4158\/ep10211.Cr","volume":"17","author":"RM Kauffmann","year":"2011","unstructured":"Kauffmann RM, Juhlin CC, Fohn LE, Broome JT, Phay JE (2011) Parathyroid carcinoma arising from four-gland hyperplasia (in eng). Endocr Pract 17:e37-42. https:\/\/doi.org\/10.4158\/ep10211.Cr","journal-title":"Endocr Pract"},{"key":"1305_CR82","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1477-7819-11-83","volume":"11","author":"SH Ng","year":"2013","unstructured":"Ng SH, Lang BH (2013) Parathyroid carcinoma in a 30-year-old man: a diagnostic and management challenge (in eng). World J Surg Oncol 11:83. https:\/\/doi.org\/10.1186\/1477-7819-11-83","journal-title":"World J Surg Oncol"},{"key":"1305_CR83","first-page":"484","volume":"44","author":"HS Barker","year":"2014","unstructured":"Barker HS, Podoll MB, Parker JR, Parker JC Jr, Crim J, Yang X (2014) Parathyroid carcinoma with intracranial metastasis at diagnosis in a patient with uncontrolled hypercalcemia (in eng). Ann Clin Lab Sci 44:484\u2013488","journal-title":"Ann Clin Lab Sci"},{"key":"1305_CR84","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/qjmed\/hcu166","volume":"108","author":"CV Tong","year":"2015","unstructured":"Tong CV, Hussein Z, Noor NM, Mohamad M, Ng WF (2015) Use of denosumab in parathyroid carcinoma with refractory hypercalcemia (in eng). QJM 108:49\u201350. https:\/\/doi.org\/10.1093\/qjmed\/hcu166","journal-title":"QJM"},{"key":"1305_CR85","doi-asserted-by":"publisher","first-page":"243","DOI":"10.7888\/juoeh.36.243","volume":"36","author":"H Mori","year":"2014","unstructured":"Mori H, Okada Y, Arao T, Tanaka Y (2014) Case of parathyroid carcinoma with a highly aggressive clinical course (in eng). J uoeh 36:243\u2013249. https:\/\/doi.org\/10.7888\/juoeh.36.243","journal-title":"J uoeh"},{"key":"1305_CR86","doi-asserted-by":"publisher","first-page":"360","DOI":"10.5507\/bp.2015.001","volume":"159","author":"H Studentova","year":"2015","unstructured":"Studentova H, Melichar B, Cincibuch J, Kaminek M, Frysak Z, Geierova M, Klein J (2015) Brain metastases of parathyroid carcinoma: Review of the literature and a case report (in eng). Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 159:360\u2013365. https:\/\/doi.org\/10.5507\/bp.2015.001","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"1305_CR87","first-page":"66","volume":"110","author":"MR Diaconescu","year":"2015","unstructured":"Diaconescu MR, Glod M, Costea I, Grigorovici M, Diaconescu S (2015) Clinicopathological phenotype of parathyroid carcinoma: therapeutic and prognostic aftermaths (in eng). Chirurgia (Bucur) 110:66\u201371","journal-title":"Chirurgia (Bucur)"},{"key":"1305_CR88","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/mph.0000000000000443","volume":"38","author":"JT Davidson","year":"2016","unstructured":"Davidson JT, Lam CG, McGee RB, Bahrami A, Diaz-Thomas A (2016) Parathyroid cancer in the pediatric patient (in eng). J Pediatr Hematol Oncol 38:32\u201337. https:\/\/doi.org\/10.1097\/mph.0000000000000443","journal-title":"J Pediatr Hematol Oncol"},{"key":"1305_CR89","doi-asserted-by":"publisher","DOI":"10.1530\/edm-17-0106","author":"M Tsoli","year":"2017","unstructured":"Tsoli M, Angelousi A, Rontogianni D, Stratakis C, Kaltsas G (2017) Atypical manifestation of parathyroid carcinoma with late-onset distant metastases (in eng). Endocrinol Diabetes Metab Case Rep. https:\/\/doi.org\/10.1530\/edm-17-0106","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"1305_CR90","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-225784","author":"G Mahajan","year":"2018","unstructured":"Mahajan G, Sacerdote A (2018) Previously unreported deletion of CDC73 involving exons 1\u201313 was detected in a patient with recurrent parathyroid carcinoma (in eng). BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2018-225784","journal-title":"BMJ Case Rep"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-021-01305-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-021-01305-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-021-01305-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T02:23:01Z","timestamp":1652494981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-021-01305-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,20]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["1305"],"URL":"https:\/\/doi.org\/10.1007\/s00774-021-01305-3","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,20]]},"assertion":[{"value":"30 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The protocol was reviewed and approved by the Research Ethics Committee of Mackay Memorial Hospital. The committee was organized under and operated in accordance with the Good Clinical Practice Guidelines (MMH-REC Number: 20MMHIS079e [Institutional Review Board reference, IRB]).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}